查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1908203

人工智慧在心臟病學領域的市場規模、佔有率和趨勢分析報告：按組件、應用、疾病、地區和細分市場預測（2026-2033 年）

AI In Cardiology Market Size, Share & Trends Analysis Report By Component, By Application, By Medical Condition, By Region, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

人工智慧在心臟病學領域的市場概覽

2025年全球心臟病學人工智慧市場規模估計為16.9億美元，預計到2033年將達到148.3億美元。

預計從 2026 年到 2033 年，其複合年成長率將達到 31.17%。全球心血管疾病盛行率的上升，加上心臟科醫師對提高診斷準確性的日益重視以及心臟影像技術的快速發展，是推動人工智慧在心臟病學領域應用不斷擴展的主要因素。

例如，Sensidia公司於2023年5月宣布開發出心臟功能檢測系統（CPS），該系統利用生物感測器和人工智慧技術來檢測心臟異常。該公司已成功資金籌措800萬美元資金，用於進一步推進其技術研發。

推動人工智慧產業在心臟病學領域發展的關鍵因素是心血管疾病（CVD）發病率的上升趨勢以及由此產生的高效醫療解決方案的需求。世界衛生組織（WHO）指出，心血管疾病仍是全球首要死因。例如，預計2022年將有1,980萬人死於心血管疾病，約佔全球死亡總數的32%。同樣，根據美國疾病管制與預防中心（CDC）預測，2023年將有919,032人死於心血管疾病，佔總死亡人數的三分之一。日益沉重的疾病負擔迫切需要開發和應用先進技術，以改善疾病管理和患者預後。

高血壓、冠狀動脈疾病、心臟衰竭和心律不整等疾病的高發給全球醫療保健系統帶來了沉重負擔。傳統的診斷和治療方法往往耗時費力，且可能缺乏提供最佳患者照護所需的準確性。人工智慧透過提高心血管疾病檢測、診斷和管理的準確性和效率，提供了一種變革性的解決方案。

此外，人工智慧在心臟病學領域的應用將促進個人化醫療的實現。透過分析個別患者數據，人工智慧可以幫助制定針對每位患者獨特需求和病情的個人化治療方案。例如，在心臟衰竭的治療中，人工智慧可以根據每位患者的特定疾病特徵和對先前治療的反應，幫助確定最有效的藥物組合和生活方式調整方案。這種個人化方法可以提高介入措施的有效性，並改善患者的整體生活品質。

人工智慧演算法和成像技術的進步正在推動市場成長。先進的機器學習和深度學習演算法的開發徹底改變了人工智慧在醫學成像領域的能力。這些先進演算法現在能夠高精度地處理大量數據，從而實現心血管疾病的早期檢測、精準診斷和個人化治療方案。例如，UltraSight於2024年6月與梅奧診所合作開發了一款由人工智慧驅動的心臟影像解決方案。這項合作的重點是開發演算法，以增強照護現場超音波在心臟評估中的應用。同樣，HeartEye Diagnostics於2025年2月開發了“Dr. Noon CVD”，這是一款用於心血管疾病風險評估的人工智慧驅動的視網膜成像系統。該系統使用非侵入性視網膜影像，取代了CT掃描和血液檢查，可在三分鐘內提供結果，其準確性與心臟電腦斷層掃描相當。

此外，人工智慧在心臟病學市場的成長主要得益於策略性舉措的增加和Start-Ups資金籌措的激增。諸如夥伴關係、新產品發布、協作和收購等策略性舉措促進了創新，並加速了人工智慧解決方案在心臟病學領域的開發和應用。例如，2024年5月，iHridAI推出了HarmonyCVI，這是一款旨在實現全面、精準心血管診斷的創新產品。 HarmonyCVI是一款先進的診斷和分析工具，利用人工智慧和機器學習技術，幫助心臟科醫生和放射科醫生更好地解讀心臟磁振造影（MRI）影像。同樣，2024年9月，雅培與iCardio.ai合作開發人工智慧成像解決方案，旨在改善心血管診斷。這些措施通常旨在將人工智慧整合到現有的醫療保健基礎設施中，以提高診斷準確性並改善患者預後。

應用案例洞察：RSIP Vision 利用 AI 驅動的胸部 CT 分割加速手術導引

RSIP Vision 開發了一種先進的基於人工智慧的解決方案，能夠根據電腦斷層掃描自動為每位患者產生複雜胸腔解剖結構的高解析度 3D 模型。這些模型對於規劃複雜的手術導航流程至關重要，透過精確的解剖視覺化，能夠實現更安全、更有效的手術介入。傳統的解決方案速度慢、穩定性差，且需要大量的人工編輯，加重了臨床工作流程的負擔。

目錄

第1章調查方法和範圍

第2章執行摘要

3. 心臟病學領域人工智慧的市場變數、趨勢和範圍

  • 市場體系展望
    • 母市場展望
    • 相關/輔助市場展望
  • 市場動態
  • 用例洞察
  • 心臟病學領域的人工智慧市場分析工具
    • 產業分析—波特五力分析
    • PESTEL 分析

第4章 心臟病學領域的人工智慧市場：按組件分類的估算和趨勢分析

  • 全球心臟病學人工智慧市場組成部分差異分析
  • 全球心臟病學人工智慧市場規模及趨勢分析（按組件分類，2021-2033 年）
  • 軟體
  • 硬體
  • 服務

第5章 人工智慧在心臟病學領域的市場應用、預測與趨勢分析

  • 全球心臟病學人工智慧應用趨勢分析
  • 2021-2033年全球心臟病學人工智慧市場規模及應用趨勢分析
  • 診斷
  • 預言
  • 藥物發現
  • 其他

第6章 心臟病學領域的人工智慧市場：依疾病分類、估算與趨勢分析

  • 全球心臟病學人工智慧市場疾病趨勢分析
  • 全球心臟病學人工智慧市場規模及趨勢分析（按疾病分類，2021-2033 年）
  • 心律不整
  • 心臟衰竭
  • 缺血性心臟疾病/冠狀動脈疾病
  • 其他

7. 心臟病學領域的人工智慧市場：區域、估算和趨勢分析

  • 區域市場佔有率分析（2025 年和 2033 年）
  • 區域市場概覽
  • 市場規模及預測趨勢分析，2021-2033年
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章 競爭情勢

  • 公司/競爭對手分類
  • 策略規劃
  • 2025年商業市場分析
  • 公司簡介/列表
    • GE Healthcare
    • Heartflow, Inc.
    • IDOVEN
    • CardiAI
    • Ultromics Limited
    • Arterys Inc.（Tempus AI）
    • Ultrasight
    • Koninklijke Philips NV
    • Vista AI
    • Viz.ai, Inc.
    • RSIP Vision
    • Cleerly, Inc.
    • Medical AI Co., Ltd.
    • anumana, Inc.
    • Aidoc
    • Circle Cardiovascular Imaging Inc.
    • Eko Health, Inc.
    • cardiomatics.com
Product Code: GVR-4-68040-047-1

AI In Cardiology Market Summary

The global AI in cardiology market size was estimated at USD 1.69 billion in 2025 and is projected to reach USD 14.83 billion by 2033, growing at a CAGR of 31.17% from 2026 to 2033. The rising global prevalence of cardiovascular diseases, coupled with the increasing focus of cardiac specialists on enhancing diagnostic precision and rapid advancements in cardiac imaging technology, are among the key factors responsible for expanding the applications of AI in cardiology.

For instance, in May 2023, Sensydia announced the development of its Cardiac Performance System (CPS), which uses biosensors and AI to detect heart abnormalities. The company secured USD 8 million in funding to advance its technology.

A primary factor driving the growth of the artificial intelligence in cardiology industry is the increasing prevalence of cardiovascular diseases (CVDs) and the consequent need for efficient & effective healthcare solutions. According to the WHO, CVD remains the leading cause of mortality worldwide. For instance, an estimated 19.8 million people died from CVDs in 2022, representing approximately 32% of all global deaths. Similarly, according to the Centers for Disease Control and Prevention (CDC), 919,032 people died from cardiovascular disease in the U.S. in 2023, equivalent to one in every three deaths. This escalating burden necessitates the development and implementation of advanced technologies to improve disease management and patient outcomes.

The high prevalence of conditions such as hypertension, coronary artery disease, heart failure, and arrhythmia puts a substantial strain on healthcare systems globally. Traditional diagnostic & treatment methods are often time-consuming & resource-intensive and are likely to lack the precision required for optimal patient care. AI offers a transformative solution by enhancing the accuracy and efficiency of CVD detection, diagnosis, and management.

Moreover, the integration of AI in cardiology facilitates the delivery of personalized medicine. By analyzing individual patient data, AI helps tailor treatment plans to address the unique needs and conditions of each patient. For instance, in managing heart failure, AI helps determine the most effective combination of medications and lifestyle modifications for each patient based on their specific disease profile and response to previous treatments. This personalized approach enhances the efficacy of interventions and improves patients' overall quality of life.

Technological advancements in AI algorithms and imaging techniques significantly drive the market growth. The development of advanced machine learning and deep learning algorithms has revolutionized the capabilities of AI in medical imaging and diagnostics. These advanced algorithms can now process vast amounts of data with high precision, allowing early detection, accurate diagnosis, and personalized treatment plans for CVDs. For instance, in June 2024, UltraSight partnered with Mayo Clinic to advance AI-driven cardiac imaging solutions. The collaboration focuses on developing algorithms that enhance point-of-care ultrasound for cardiac assessments. Similarly, in February 2025, Heart Eye Diagnostics developed Dr.Noon CVD, an AI-driven retinal imaging system for cardiovascular disease (CVD) risk assessment. Using noninvasive retinal images instead of CT or blood tests, it offers accuracy comparable to heart CT scans and delivers results in three minutes.

In addition,the growth of AI in cardiology market is significantly propelled by the rise in strategic initiatives and the surge in startup funding. Strategic initiatives, including partnerships, new launches, collaborations, & acquisitions, foster innovation and accelerate the development & deployment of AI solutions in cardiology. For instance, in May 2024, iHridAI launched its novel, innovative product, HarmonyCVI, designed for thorough and precise cardiovascular diagnosis. HarmonyCVI is an advanced diagnostic and analysis tool that utilizes AI & machine learning to assist cardiologists and radiologists in the improved interpretation of cardiac MRI scans. Similarly, in September 2024, Abbott partnered with iCardio.ai to develop artificial intelligence imaging solutions to improve cardiovascular diagnostics. These initiatives are often aimed at integrating AI with existing healthcare infrastructure to enhance diagnostic accuracy and improve patient outcomes.

Case Study Insights: Accelerating Surgical Navigation through Ai-Driven Chest Ct Segmentation by RSIP Vision

RSIP Vision developed an advanced AI-based solution to automatically generate high-resolution 3D models of complex, patient-specific chest anatomies from CT scans. These models are crucial for planning intricate surgical navigation procedures, where precise anatomical visualization informs safer and more effective interventions. Conventional solutions were slow, lacked robustness, and required extensive manual editing, burdening clinical workflows.

Global AI In Cardiology Market Report Segmentation

This report forecasts revenue growth and provides at the global, regional, and country levels an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global AI in cardiology market report based on component, application, medical condition, and region:

  • Component Outlook (Revenue, USD Million, 2021 - 2033)
  • Software
  • Hardware
  • Services
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Diagnosis
  • Prediction
  • Drug Discovery
  • Others
  • Medical Condition Outlook (Revenue, USD Million, 2021 - 2033)
  • Cardiac Arrhythmias
  • Heart Failure
  • Ischemic Heart Disease /CAD
  • Others
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definitions
    • 1.2.1. Component Segment
    • 1.2.2. Application Segment
    • 1.2.3. Medical Condition Segment
  • 1.3. Information analysis
    • 1.3.1. Market formulation & data visualization
  • 1.4. Data validation & publishing
  • 1.5. Information Procurement
    • 1.5.1. Primary Research
  • 1.6. Information or Data Analysis
  • 1.7. Market Formulation & Validation
  • 1.8. Market Model
  • 1.9. Total Market: CAGR Calculation
  • 1.10. Objectives
    • 1.10.1. Objective 1
    • 1.10.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Insights Landscape

Chapter 3. Artificial Intelligence in Cardiology Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook.
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Growing burden of cardiovascular diseases and the need for efficient healthcare solutions
      • 3.2.1.2. Increasing strategic initiatives in AI technologies
      • 3.2.1.3. Rapid technological advancements and growing adoption of remote patient monitoring solutions
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Highly regulated industry
      • 3.2.2.2. High implementation and procurement costs
      • 3.2.2.3. Shortage of healthcare personnel in information technology
    • 3.2.3. Market opportunity analysis
    • 3.2.4. Market challenges analysis
  • 3.3. Case Study Insights
  • 3.4. Artificial Intelligence in Cardiology Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic landscape
      • 3.4.2.4. Environmental Landscape
      • 3.4.2.5. Legal Landscape
      • 3.4.2.6. Social Landscape

Chapter 4. Artificial Intelligence in Cardiology Market: Component Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Artificial Intelligence in Cardiology Market Component Movement Analysis
  • 4.3. Global Artificial Intelligence in Cardiology Market Size & Trend Analysis, by Component, 2021 to 2033 (USD Million)
  • 4.4. Software
    • 4.4.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  • 4.5. Hardware
    • 4.5.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  • 4.6. Services
    • 4.6.1. Market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 5. Artificial Intelligence in Cardiology Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Artificial Intelligence in Cardiology Market Application Movement Analysis
  • 5.3. Global Artificial Intelligence in Cardiology Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
  • 5.4. Diagnosis
    • 5.4.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.5. Prediction
    • 5.5.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.6. Drug Discovery
    • 5.6.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.7. Others
    • 5.7.1. Market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 6. Artificial Intelligence in Cardiology Market: Medical Condition Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global Artificial Intelligence in Cardiology Market Medical Condition Movement Analysis
  • 6.3. Global Artificial Intelligence in Cardiology Market Size & Trend Analysis, by Medical Condition, 2021 to 2033 (USD Million)
  • 6.4. Cardiac Arrhythmias
    • 6.4.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.5. Heart Failure
    • 6.5.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.6. Ischemic Heart Disease /CAD
    • 6.6.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.7. Others
    • 6.7.1. Market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 7. Artificial Intelligence in Cardiology Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2025 & 2033
  • 7.2. Regional Market Dashboard
  • 7.3. Market Size & Forecasts Trend Analysis, 2021 to 2033
  • 7.4. North America
    • 7.4.1. U.S.
      • 7.4.1.1. Key country dynamics
      • 7.4.1.2. Regulatory framework
      • 7.4.1.3. Competitive scenario
      • 7.4.1.4. U.S. market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.4.2. Canada
      • 7.4.2.1. Key country dynamics
      • 7.4.2.2. Regulatory framework
      • 7.4.2.3. Competitive scenario
      • 7.4.2.4. Canada market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.4.3. Mexico
      • 7.4.3.1. Key country dynamics
      • 7.4.3.2. Regulatory framework
      • 7.4.3.3. Competitive scenario
      • 7.4.3.4. Mexico market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.5. Europe
    • 7.5.1. UK
      • 7.5.1.1. Key country dynamics
      • 7.5.1.2. Regulatory framework
      • 7.5.1.3. Competitive scenario
      • 7.5.1.4. UK market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.2. Germany
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework
      • 7.5.2.3. Competitive scenario
      • 7.5.2.4. Germany market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.3. France
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Regulatory framework
      • 7.5.3.3. Competitive scenario
      • 7.5.3.4. France market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.4. Italy
      • 7.5.4.1. Key country dynamics
      • 7.5.4.2. Regulatory framework
      • 7.5.4.3. Competitive scenario
      • 7.5.4.4. Italy market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.5. Spain
      • 7.5.5.1. Key country dynamics
      • 7.5.5.2. Regulatory framework
      • 7.5.5.3. Competitive scenario
      • 7.5.5.4. Spain market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.6. Norway
      • 7.5.6.1. Key country dynamics
      • 7.5.6.2. Regulatory framework
      • 7.5.6.3. Competitive scenario
      • 7.5.6.4. Norway market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.7. Sweden
      • 7.5.7.1. Key country dynamics
      • 7.5.7.2. Regulatory framework
      • 7.5.7.3. Competitive scenario
      • 7.5.7.4. Sweden market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.8. Denmark
      • 7.5.8.1. Key country dynamics
      • 7.5.8.2. Regulatory framework
      • 7.5.8.3. Competitive scenario
      • 7.5.8.4. Denmark market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Japan
      • 7.6.1.1. Key country dynamics
      • 7.6.1.2. Regulatory framework
      • 7.6.1.3. Competitive scenario
      • 7.6.1.4. Japan market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.2. China
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework
      • 7.6.2.3. Competitive scenario
      • 7.6.2.4. China market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.3. India
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Regulatory framework
      • 7.6.3.3. Competitive scenario
      • 7.6.3.4. India market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.4. Australia
      • 7.6.4.1. Key country dynamics
      • 7.6.4.2. Regulatory framework
      • 7.6.4.3. Competitive scenario
      • 7.6.4.4. Australia market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.5. South Korea
      • 7.6.5.1. Key country dynamics
      • 7.6.5.2. Regulatory framework
      • 7.6.5.3. Competitive scenario
      • 7.6.5.4. South Korea market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.6. Thailand
      • 7.6.6.1. Key country dynamics
      • 7.6.6.2. Regulatory framework
      • 7.6.6.3. Competitive scenario
      • 7.6.6.4. Thailand market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Brazil
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Regulatory framework
      • 7.7.1.3. Competitive scenario
      • 7.7.1.4. Brazil market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.7.2. Argentina
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory framework
      • 7.7.2.3. Competitive scenario
      • 7.7.2.4. Argentina market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.8. MEA
    • 7.8.1. South Africa
      • 7.8.1.1. Key country dynamics
      • 7.8.1.2. Regulatory framework
      • 7.8.1.3. Competitive scenario
      • 7.8.1.4. South Africa market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.8.2. Saudi Arabia
      • 7.8.2.1. Key country dynamics
      • 7.8.2.2. Regulatory framework
      • 7.8.2.3. Competitive scenario
      • 7.8.2.4. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.8.3. UAE
      • 7.8.3.1. Key country dynamics
      • 7.8.3.2. Regulatory framework
      • 7.8.3.3. Competitive scenario
      • 7.8.3.4. UAE market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.8.4. Kuwait
      • 7.8.4.1. Key country dynamics
      • 7.8.4.2. Regulatory framework
      • 7.8.4.3. Competitive scenario
      • 7.8.4.4. Kuwait market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company/Competition Categorization
  • 8.2. Strategy Mapping
  • 8.3. Company Market Position Analysis, 2025
  • 8.4. Company Profiles/Listing
    • 8.4.1. GE Healthcare
      • 8.4.1.1. Company overview
      • 8.4.1.2. Financial performance
      • 8.4.1.3. Technology type benchmarking
      • 8.4.1.4. Strategic initiatives
    • 8.4.2. Heartflow, Inc.
      • 8.4.2.1. Company overview
      • 8.4.2.2. Financial performance
      • 8.4.2.3. Technology type benchmarking
      • 8.4.2.4. Strategic initiatives
    • 8.4.3. IDOVEN
      • 8.4.3.1. Company overview
      • 8.4.3.2. Financial performance
      • 8.4.3.3. Technology type benchmarking
      • 8.4.3.4. Strategic initiatives
    • 8.4.4. CardiAI
      • 8.4.4.1. Company overview
      • 8.4.4.2. Financial performance
      • 8.4.4.3. Technology type benchmarking
      • 8.4.4.4. Strategic initiatives
    • 8.4.5. Ultromics Limited
      • 8.4.5.1. Company overview
      • 8.4.5.2. Financial performance
      • 8.4.5.3. Technology type benchmarking
      • 8.4.5.4. Strategic initiatives
    • 8.4.6. Arterys Inc. (Tempus AI)
      • 8.4.6.1. Company overview
      • 8.4.6.2. Financial performance
      • 8.4.6.3. Technology type benchmarking
      • 8.4.6.4. Strategic initiatives
    • 8.4.7. Ultrasight
      • 8.4.7.1. Company overview
      • 8.4.7.2. Financial performance
      • 8.4.7.3. Technology type benchmarking
      • 8.4.7.4. Strategic initiatives
    • 8.4.8. Koninklijke Philips N.V.
      • 8.4.8.1. Company overview
      • 8.4.8.2. Financial performance
      • 8.4.8.3. Technology type benchmarking
      • 8.4.8.4. Strategic initiatives
    • 8.4.9. Vista AI
      • 8.4.9.1. Company overview
      • 8.4.9.2. Financial performance
      • 8.4.9.3. Technology type benchmarking
      • 8.4.9.4. Strategic initiatives
    • 8.4.10. Viz.ai, Inc.
      • 8.4.10.1. Company overview
      • 8.4.10.2. Financial performance
      • 8.4.10.3. Technology type benchmarking
      • 8.4.10.4. Strategic initiatives
    • 8.4.11. RSIP Vision
      • 8.4.11.1. Company overview
      • 8.4.11.2. Financial performance
      • 8.4.11.3. Technology type benchmarking
      • 8.4.11.4. Strategic initiatives
    • 8.4.12. Cleerly, Inc.
      • 8.4.12.1. Company overview
      • 8.4.12.2. Financial performance
      • 8.4.12.3. Technology type benchmarking
      • 8.4.12.4. Strategic initiatives
    • 8.4.13. Medical AI Co., Ltd.
      • 8.4.13.1. Company overview
      • 8.4.13.2. Financial performance
      • 8.4.13.3. Technology type benchmarking
      • 8.4.13.4. Strategic initiatives
    • 8.4.14. anumana, Inc.
      • 8.4.14.1. Company overview
      • 8.4.14.2. Financial performance
      • 8.4.14.3. Technology type benchmarking
      • 8.4.14.4. Strategic initiatives
    • 8.4.15. Aidoc
      • 8.4.15.1. Company overview
      • 8.4.15.2. Financial performance
      • 8.4.15.3. Technology type benchmarking
      • 8.4.15.4. Strategic initiatives
    • 8.4.16. Circle Cardiovascular Imaging Inc.
      • 8.4.16.1. Company overview
      • 8.4.16.2. Financial performance
      • 8.4.16.3. Technology type benchmarking
      • 8.4.16.4. Strategic initiatives
    • 8.4.17. Eko Health, Inc.
      • 8.4.17.1. Company overview
      • 8.4.17.2. Financial performance
      • 8.4.17.3. Technology type benchmarking
      • 8.4.17.4. Strategic initiatives
    • 8.4.18. cardiomatics.com
      • 8.4.18.1. Company overview
      • 8.4.18.2. Financial performance
      • 8.4.18.3. Technology type benchmarking
      • 8.4.18.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 North America AI in cardiology market, by region, 2021 - 2033 (USD Million)
  • Table 3 North America AI in cardiology market, by component, 2021 - 2033 (USD Million)
  • Table 4 North America AI in cardiology market, by application, 2021 - 2033 (USD Million)
  • Table 5 North America AI in cardiology market, by medical condition, 2021 - 2033 (USD Million)
  • Table 6 U.S. AI in cardiology market, by component, 2021 - 2033 (USD Million)
  • Table 7 U.S. AI in cardiology market, by application, 2021 - 2033 (USD Million)
  • Table 8 U.S. AI in cardiology market, by medical condition, 2021 - 2033 (USD Million)
  • Table 9 Canada AI in cardiology market, by component, 2021 - 2033 (USD Million)
  • Table 10 Canada AI in cardiology market, by application, 2021 - 2033 (USD Million)
  • Table 11 Canada AI in cardiology market, by medical condition, 2021 - 2033 (USD Million)
  • Table 12 Mexico AI in cardiology market, by component, 2021 - 2033 (USD Million)
  • Table 13 Mexico AI in cardiology market, by application, 2021 - 2033 (USD Million)
  • Table 14 Mexico AI in cardiology market, by medical condition, 2021 - 2033 (USD Million)
  • Table 15 Europe AI in cardiology market, by region, 2021 - 2033 (USD Million)
  • Table 16 Europe AI in cardiology market, by component, 2021 - 2033 (USD Million)
  • Table 17 Europe AI in cardiology market, by application, 2021 - 2033 (USD Million)
  • Table 18 Europe AI in cardiology market, by medical condition, 2021 - 2033 (USD Million)
  • Table 19 Germany AI in cardiology market, by component, 2021 - 2033 (USD Million)
  • Table 20 Germany AI in cardiology market, by application, 2021 - 2033 (USD Million)
  • Table 21 Germany AI in cardiology market, by medical condition, 2021 - 2033 (USD Million)
  • Table 22 UK AI in cardiology market, by component, 2021 - 2033 (USD Million)
  • Table 23 UK AI in cardiology market, by application, 2021 - 2033 (USD Million)
  • Table 24 UK AI in cardiology market, by medical condition, 2021 - 2033 (USD Million)
  • Table 25 France AI in cardiology market, by component, 2021 - 2033 (USD Million)
  • Table 26 France AI in cardiology market, by application, 2021 - 2033 (USD Million)
  • Table 27 France AI in cardiology market, by medical condition, 2021 - 2033 (USD Million)
  • Table 28 Italy AI in cardiology market, by component, 2021 - 2033 (USD Million)
  • Table 29 Italy AI in cardiology market, by application, 2021 - 2033 (USD Million)
  • Table 30 Italy AI in cardiology market, by medical condition, 2021 - 2033 (USD Million)
  • Table 31 Spain AI in cardiology market, by component, 2021 - 2033 (USD Million)
  • Table 32 Spain AI in cardiology market, by application, 2021 - 2033 (USD Million)
  • Table 33 Spain AI in cardiology market, by medical condition, 2021 - 2033 (USD Million)
  • Table 34 Denmark AI in cardiology market, by component, 2021 - 2033 (USD Million)
  • Table 35 Denmark AI in cardiology market, by application, 2021 - 2033 (USD Million)
  • Table 36 Denmark AI in cardiology market, by medical condition, 2021 - 2033 (USD Million)
  • Table 37 Sweden AI in cardiology market, by component, 2021 - 2033 (USD Million)
  • Table 38 Sweden AI in cardiology market, by application, 2021 - 2033 (USD Million)
  • Table 39 Sweden AI in cardiology market, by medical condition, 2021 - 2033 (USD Million)
  • Table 40 Norway AI in cardiology market, by component, 2021 - 2033 (USD Million)
  • Table 41 Norway AI in cardiology market, by application, 2021 - 2033 (USD Million)
  • Table 42 Norway AI in cardiology market, by medical condition, 2021 - 2033 (USD Million)
  • Table 43 North America AI in cardiology market, by component, 2021 - 2033 (USD Million)
  • Table 44 Asia Pacific AI in cardiology market, by region, 2021 - 2033 (USD Million)
  • Table 45 Asia Pacific AI in cardiology market, by component, 2021 - 2033 (USD Million)
  • Table 46 Asia Pacific AI in cardiology market, by application, 2021 - 2033 (USD Million)
  • Table 47 Asia Pacific AI in cardiology market, by medical condition, 2021 - 2033 (USD Million)
  • Table 48 China AI in cardiology market, by component, 2021 - 2033 (USD Million)
  • Table 49 China AI in cardiology market, by application, 2021 - 2033 (USD Million)
  • Table 50 China AI in cardiology market, by medical condition, 2021 - 2033 (USD Million)
  • Table 51 Japan AI in cardiology market, by component, 2021 - 2033 (USD Million)
  • Table 52 Japan AI in cardiology market, by application, 2021 - 2033 (USD Million)
  • Table 53 Japan AI in cardiology market, by medical condition, 2021 - 2033 (USD Million)
  • Table 54 India AI in cardiology market, by component, 2021 - 2033 (USD Million)
  • Table 55 India AI in cardiology market, by application, 2021 - 2033 (USD Million)
  • Table 56 India AI in cardiology market, by medical condition, 2021 - 2033 (USD Million)
  • Table 57 South Korea AI in cardiology market, by component, 2021 - 2033 (USD Million)
  • Table 58 South Korea AI in cardiology market, by application, 2021 - 2033 (USD Million)
  • Table 59 South Korea AI in cardiology market, by medical condition, 2021 - 2033 (USD Million)
  • Table 60 Australia AI in cardiology market, by component, 2021 - 2033 (USD Million)
  • Table 61 Australia AI in cardiology market, by application, 2021 - 2033 (USD Million)
  • Table 62 Australia AI in cardiology market, by medical condition, 2021 - 2033 (USD Million)
  • Table 63 Thailand AI in cardiology market, by component, 2021 - 2033 (USD Million)
  • Table 64 Thailand AI in cardiology market, by application, 2021 - 2033 (USD Million)
  • Table 65 Thailand AI in cardiology market, by medical condition, 2021 - 2033 (USD Million)
  • Table 66 Latin America AI in cardiology market, by region, 2021 - 2033 (USD Million)
  • Table 67 Latin America AI in cardiology market, by component, 2021 - 2033 (USD Million)
  • Table 68 Latin America AI in cardiology market, by application, 2021 - 2033 (USD Million)
  • Table 69 Latin America AI in cardiology market, by medical condition, 2021 - 2033 (USD Million)
  • Table 70 Brazil AI in cardiology market, by component, 2021 - 2033 (USD Million)
  • Table 71 Brazil AI in cardiology market, by component, 2021 - 2033 (USD Million)
  • Table 72 Brazil AI in cardiology market, by medical condition, 2021 - 2033 (USD Million)
  • Table 73 Argentina AI in cardiology market, by component, 2021 - 2033 (USD Million)
  • Table 74 Argentina AI in cardiology market, by application, 2021 - 2033 (USD Million)
  • Table 75 Argentina AI in cardiology market, by medical condition, 2021 - 2033 (USD Million)
  • Table 76 MEA AI in cardiology market, by region, 2021 - 2033 (USD Million)
  • Table 77 MEA AI in cardiology market, by component, 2021 - 2033 (USD Million)
  • Table 78 MEA AI in cardiology market, by application, 2021 - 2033 (USD Million)
  • Table 79 MEA AI in cardiology market, by medical condition, 2021 - 2033 (USD Million)
  • Table 80 South Africa AI in cardiology market, by component, 2021 - 2033 (USD Million)
  • Table 81 South Africa AI in cardiology market, by application, 2021 - 2033 (USD Million)
  • Table 82 South Africa AI in cardiology market, by medical condition, 2021 - 2033 (USD Million)
  • Table 83 Saudi Arabia AI in cardiology market, by component, 2021 - 2033 (USD Million)
  • Table 84 Saudi Arabia AI in cardiology market, by application, 2021 - 2033 (USD Million)
  • Table 85 Saudi Arabia AI in cardiology market, by medical condition, 2021 - 2033 (USD Million)
  • Table 86 UAE AI in cardiology market, by component, 2021 - 2033 (USD Million)
  • Table 87 UAE AI in cardiology market, by application, 2021 - 2033 (USD Million)
  • Table 88 UAE AI in cardiology market, by medical condition, 2021 - 2033 (USD Million)
  • Table 89 Kuwait AI in cardiology market, by component, 2021 - 2033 (USD Million)
  • Table 90 Kuwait AI in cardiology market, by application, 2021 - 2033 (USD Million)
  • Table 91 Kuwait AI in cardiology market, by medical condition, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Artificial intelligence in cardiology market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Commodity flow analysis
  • Fig. 5 Parent market analysis
  • Fig. 6 AI in Cardiology Market snapshot
  • Fig. 7 AI in Cardiology Market segment snapshot (Part 1)
  • Fig. 8 AI in Cardiology Market segment snapshot (Part 2)
  • Fig. 9 AI in Cardiology Market competitive landscape snapshot
  • Fig. 10 Market research process
  • Fig. 11 Parent market outlook (USD Billion) (2025)
  • Fig. 12 AI in cardiology market dynamics
  • Fig. 13 Few notable funding in AI in cardiology Market
  • Fig. 14 Comparison between AI-integrated healthcare and traditional healthcare
  • Fig. 15 AI in cardiology market: Porter's five forces analysis
  • Fig. 16 AI in cardiology market: PESTLE analysis
  • Fig. 17 Artificial intelligence in cardiology market, component outlook key takeaways (USD million)
  • Fig. 18 Artificial intelligence in cardiology market: Component movement analysis, 2025 & 2033 (USD Million)
  • Fig. 19 Software market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 20 Hardware market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 21 Services market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 22 Artificial intelligence in cardiology market, application outlook key takeaways (USD Million)
  • Fig. 23 Artificial intelligence in cardiology market: Application movement analysis, 2025 & 2033 (USD Million)
  • Fig. 24 Diagnosis market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 25 Prediction market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 26 Drug discovery market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 27 Others market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 28 Artificial intelligence in cardiology market, medical condition outlook key takeaways (USD Million)
  • Fig. 29 Artificial intelligence in cardiology market: Medical condition movement analysis, 2025 & 2033 (USD Million)
  • Fig. 30 Cardiac arrhythmias market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 31 Heart failure market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 32 Ischemic heart disease/CAD market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 33 Others market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 34 Regional marketplace: Key takeaways
  • Fig. 35 AI in Cardiology Market: Regional outlook
  • Fig. 36 North America artificial intelligence in cardiology market, 2021 - 2033 (USD Million)
  • Fig. 37 Key country dynamics
  • Fig. 38 U.S artificial intelligence in cardiology market, 2021 - 2033 (USD Million)
  • Fig. 39 Key country dynamics
  • Fig. 40 Canada artificial intelligence in cardiology software market, 2021 - 2033 (USD Million)
  • Fig. 41 Key country dynamics
  • Fig. 42 Mexico artificial intelligence in cardiology market, 2021 - 2033 (USD Million)
  • Fig. 43 Europe artificial intelligence in cardiology market, 2021 - 2033 (USD Million)
  • Fig. 44 Key country dynamics
  • Fig. 45 UK artificial intelligence in cardiology market, 2021 - 2033 (USD Million)
  • Fig. 46 Key country dynamics
  • Fig. 47 Germany artificial intelligence in cardiology market, 2021 - 2033 (USD Million)
  • Fig. 48 Key country dynamics
  • Fig. 49 France artificial intelligence in cardiology market, 2021 - 2033 (USD Million)
  • Fig. 50 Key country dynamics
  • Fig. 51 Italy artificial intelligence in cardiology market, 2021 - 2033 (USD Million)
  • Fig. 52 Key country dynamics
  • Fig. 53 Spain artificial intelligence in cardiology market, 2021 - 2033 (USD Million)
  • Fig. 54 Key country dynamics
  • Fig. 55 Sweden artificial intelligence in cardiology market, 2021 - 2033 (USD Million)
  • Fig. 56 Key country dynamics
  • Fig. 57 Denmark artificial intelligence in cardiology market, 2021 - 2033 (USD Million)
  • Fig. 58 Key country dynamics
  • Fig. 59 Norway artificial intelligence in cardiology market, 2021 - 2033 (USD Million)
  • Fig. 60 Asia Pacific artificial intelligence in cardiology market, 2021 - 2033 (USD Million)
  • Fig. 61 Key country dynamics
  • Fig. 62 Japan artificial intelligence in cardiology market, 2021 - 2033 (USD Million)
  • Fig. 63 Key country dynamics
  • Fig. 64 China artificial intelligence in cardiology software market, 2021 - 2033 (USD Million)
  • Fig. 65 Key country dynamics
  • Fig. 66 India artificial intelligence in cardiology market, 2021 - 2033 (USD Million)
  • Fig. 67 Key country dynamics
  • Fig. 68 Australia artificial intelligence in cardiology market, 2021 - 2033 (USD Million)
  • Fig. 69 Key country dynamics
  • Fig. 70 Thailand artificial intelligence in cardiology market, 2021 - 2033 (USD Million)
  • Fig. 71 Key country dynamics
  • Fig. 72 South Korea artificial intelligence in cardiology market, 2021 - 2033 (USD Million)
  • Fig. 73 Latin America artificial intelligence in cardiology market, 2021 - 2033 (USD Million)
  • Fig. 74 Key country dynamics
  • Fig. 75 Brazil artificial intelligence in cardiology market, 2021 - 2033 (USD Million)
  • Fig. 76 Key country dynamics
  • Fig. 77 Argentina artificial intelligence in cardiology software market, 2021 - 2033 (USD Million)
  • Fig. 78 MEA artificial intelligence in cardiology market, 2021 - 2033 (USD Million)
  • Fig. 79 Key country dynamics
  • Fig. 80 South Africa artificial intelligence in cardiology market, 2021 - 2033 (USD Million)
  • Fig. 81 Key country dynamics
  • Fig. 82 Saudi Arabia artificial intelligence in cardiology market, 2021 - 2033 (USD Million)
  • Fig. 83 Key country dynamics
  • Fig. 84 UAE artificial intelligence in cardiology market, 2021 - 2033 (USD Million)
  • Fig. 85 Key country dynamics
  • Fig. 86 Kuwait artificial intelligence in cardiology market, 2021 - 2033 (USD Million)
  • Fig. 87 Company Categorization
  • Fig. 88 Company market position/share analysis, 2025
  • Fig. 89 Strategic Framework